LEMTRADA REMS Healthcare Facility Enrollment

• Healthcare facilities must be enrolled in the LEMTRADA REMS to be able to dispense/administer LEMTRADA for patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of LEMTRADA should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS

1. Designate an authorized representative
2. Register the authorized representative with the LEMTRADA REMS Training Center
3. Authorized representative must review the LEMTRADA REMS Education Program through the online module on this site
4. After completing the online module, complete and sign the LEMTRADA REMS Healthcare Facility Enrollment Form. This enrollment must be renewed every 2 years
5. Implement the necessary staff training and processes to comply with the LEMTRADA REMS requirements